Role of fructosamine in management of gestational diabetes

ABSTRACT

Estimation of serum fructosamine can be used for screening and diagnosis of gestational diabetes and as an index of diabetic control. This measurement in late pregnancy is also of value in the detection of the foetal outcome. In this study, fructosamine estimation at 35-37 weeks gestation detected 83 percent of cases of gestational diabetes. There was a significant correlation between the diabetic group at 35-37 weeks gestation and also at the time of delivery. These results suggested that fructosamine estimation is an effective reflection of blood glucose control during the previous 1-3 weeks. There was also a significant correlation between maternal fructosamine level at 35-37 weeks gestation and at delivery time with foetal growth and birth weight